The Directorate General of Foreign Trade (DGFT) has notified four new Standard Input-Output Norms (SIONs) under the Chemical and Allied Products category, identified as Product Code ‘A’. Issued through Public Notice No. 36/2026-27 dated 23 October 2026, the notification introduces new norms for specified doxycycline tablet formulations and clobetasol propionate.

The new SIONs, numbered A-3715, A-3716, A-3717 and A-3718, establish prescribed input-output quantities for the listed export products. The measure aims to facilitate the faster issuance of Advance Authorisations by Regional Authorities and ensure uniform application of the norms.

What Are the New SIONs for Chemical and Allied Products?

Standard Input-Output Norms specify the quantity of inputs permitted for producing a defined quantity of an export product under the applicable foreign trade framework.

Under the latest DGFT public notice, four new entries have been introduced for the Chemical and Allied Products group. Three entries cover doxycycline tablets, while the fourth relates to clobetasol propionate.

Details of the Four New SIONs

Note: The product descriptions and quantities above follow the details provided in DGFT Public Notice No. 36/2026-27. Exporters should verify the original notification before applying the norms.

How Will the New SIONs Affect Advance Authorisation?

The notification aims to facilitate the expeditious issuance of Advance Authorisations by Regional Authorities and promote consistency in the application of input-output norms.

1. Defined Input-Output Quantities

The new SION entries specify the prescribed input quantities for the listed export products. This gives exporters and relevant authorities a defined reference for the products covered by the notification.

2. Faster Processing of Advance Authorisations

The stated objective is to facilitate faster issuance of Advance Authorisations by Regional Authorities. Exporters dealing with the specified products should review the applicable SION entry when preparing their authorisation applications.

3. Uniform Application of Norms

The introduction of specific norms is intended to ensure uniformity in how the prescribed input-output quantities are applied to the covered products.

What Should Exporters Do After the DGFT Notification?

Exporters and pharmaceutical manufacturers dealing with the listed products should:

• Review Public Notice No. 36/2026-27 dated 23 October 2026.

• Identify the SION entry applicable to the intended export product.

• Verify the prescribed input quantities and product specifications against the official notification.

• Check the applicable Advance Authorisation requirements under the Foreign Trade Policy and Handbook of Procedures.

• Maintain appropriate supporting documentation for the inputs used and products exported.

Note on the DGFT Notification

The four new SIONs fall under Product Group ‘A’ — Chemical and Allied Products. The notice was issued under paragraph 1.03 of the Foreign Trade Policy 2023, as amended from time to time.

The notification covers only the specified product entries. Exporters should not assume that these norms automatically apply to other formulations or products.

Conclusion

The introduction of SIONs A-3715, A-3716, A-3717 and A-3718 is an important update for exporters dealing with the specified doxycycline tablet formulations and clobetasol propionate. By defining input-output quantities for these products, DGFT aims to facilitate Advance Authorisation issuance and ensure consistent application of the norms.

Businesses should review the notification, confirm the relevant SION entry and check the applicable authorisation requirements before proceeding with export-related compliance.

Stay updated with Preface Venture for the latest DGFT notifications, Foreign Trade Policy amendments, export-import compliance updates and Advance Authorisation developments.